Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2012 / Cilt: 20 - Sayı: 4

Graft versus host disease after coronary bypass surgery

Koroner baypas ameliyatı sonrası gelişen graft versus host hastalığı

Pages
890–892
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On day 4, the patient died due to sepsis and disseminated intravascular coagulation in the ICU.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Transfusion associated graft versus host disease ( TA-GVHD) is a rare disease with a high mortality rates.
📊
Key Findings & Data:In this article, we present a 74 -yea r- old fema le case who was hospita lized in the intensive care unit (ICU) due to fever, rash, elevated liver enzymes, uremia, pancytopenia, jaundice, respiratory deficiency and gastrointestinal bleeding at two weeks following coronary artery bypass graft (CABG) surgery.
💡
Conclusion & Impact:On day 4, the patient died due to sepsis and disseminated intravascular coagulation in the ICU.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Transfusion associated graft versus host disease ( TA-GVHD) is a rare disease with a high mortality rates. Due to low potential to complete recovery with the treatment, supportive care is usually administered. Late diagnosis is common due to nonspecific signs and symptoms in routine clinical practice. History of blood product transfusion is a critical clue indicating this disease. In this article, we present a 74 -yea r- old fema le case who was hospita lized in the intensive care unit (ICU) due to fever, rash, elevated liver enzymes, uremia, pancytopenia, jaundice, respiratory deficiency and gastrointestinal bleeding at two weeks following coronary artery bypass graft (CABG) surgery. She had received blood from relative donors two weeks ago before CABG surgery. The patient was diagnosed with graft versus host disease through biopsy samples taken from skin rash. On day 4, the patient died due to sepsis and disseminated intravascular coagulation in the ICU.

Özet

Kan transfüzyonu ile ilişkili graft versus host hastalığı (TA-GVHH), nadir görülen ve mortalite oranı yüksek bir hastalıktır. Tedavi ile tamamen iyileşme ihtimali çok düşük olup, genellikle destek tedavisi yapılabilmektedir. Rutin klinik uygulamada özgün olmayan bulgu ve belirtiler nedeniyle tanıda gecikilmektedir. Kan ürünleri transfüzyon öyküsü olması bu hastalığı düşündüren önemli bir ipucudur. Bu yazıda koroner arter baypas greft (KABG) ameliyatının ikinci haftasında ateş, deri döküntüsü, karaciğer enzimlerinde yükselme, üremi, pansitopeni, ikter, solunum yetmezliği ve gastrointestinal kanama ile hastanemiz yoğun bakım ünitesinde takip edilen 74 yaşındaki kadın olgu sunuldu. Hastaya iki hafta önce KABG ameliyatı öncesinde yakın akrabalarından kan transfüzyonu uygulanmıştı. Cilt döküntüsünden yapılan biyopsi ile hastaya graft versus host hastalığı tanısı kondu. Yoğun bakım ünitesinde 4. günde sepsis ve yaygın intravasküler koagülopati nedeniyle hasta kaybedildi.

🔖

Cite This Article

FURUNCUOĞLU, Y., ÖZKER, E., ŞENGÜL, C. (2022). Graft versus host disease after coronary bypass surgery. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 20 - Sayı: 4, 890–892. https://ajindex.com/articles/424759

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Karadoğan İ. Transfüzyon ve immünomodülasyon. V. Çukurova Anestezi Günleri 28-29 Mayıs 2004 Adana. 2.Kanter MH. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives? Transfusion 1992;32:323-7. 3.Oto OA, Paydas S, Baslamisli F, Tuncer I, Ergin M, Kalakoc E, et al. Transfusion-associated graft-versus-host disease. Eur J Intern Med 2006;17:151-6. 4.Galel S, Malone III JM, Viele MK. Transfusion medicine. In: Greer JP, Foerster J, Lukens JN, editors. Wintrobe’s clinical hematology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 862-63. 5.Allanki SD, Shailesh RS, Dandamudi R. Transfusion associated graft versus host disease in an immunocompetent individual. Indian Journal of Critical Care Medicine 2006;10:47-9. 6.Aydogdu I, Kaya E, Kulu I. Transfüzyon ilişkili graft versus host hastalığı: Beş olgunun sunumu. Turkish Journal of Haemotology (Suppl 3) 2003;20:87. 7.Ahya R, Douglas JG, Watson HG. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting. Heart 1998;80:299-300. 8.Spector D. Transfusion-associated graft-versus-host disease: an overview and two case reports. Oncol Nurs Forum 1995;22:97-101. 9.Yasuura K, Okamoto H, Matsuura A. Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery. J Cardiovasc Surg (Torino) 2000;41:377-80. 10.Ohto H, Anderson KC. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 1996;10:31-43. 11.Triulzi D, Duquesnoy R, Nichols L, Clark K, Jukic D, Zeevi A, et al. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion 2006;46:885-8